2.42
-0.04(-1.63%)
Currency In USD
| Previous Close | 2.46 |
| Open | 2.44 |
| Day High | 2.49 |
| Day Low | 2.4 |
| 52-Week High | 11.66 |
| 52-Week Low | 1.87 |
| Volume | 43,030 |
| Average Volume | 690,000 |
| Market Cap | 9.2M |
| PE | -0.2 |
| EPS | -12.05 |
| Moving Average 50 Days | 2.33 |
| Moving Average 200 Days | 3.62 |
| Change | -0.04 |
If you invested $1000 in Avalon GloboCare Corp. (ALBT) since IPO date, it would be worth $7.17 as of September 29, 2025 at a share price of $2.42. Whereas If you bought $1000 worth of Avalon GloboCare Corp. (ALBT) shares 5 years ago, it would be worth $10.98 as of September 29, 2025 at a share price of $2.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom
GlobeNewswire Inc.
Aug 28, 2025 1:00 PM GMT
FREEHOLD, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that it will launch the sales of KetoAir™ breathalyzer devic
Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders
GlobeNewswire Inc.
Jul 28, 2025 1:00 PM GMT
FREEHOLD, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that its subsidiary, Q&A Distribution, LLC, has entered into
Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong
GlobeNewswire Inc.
Jul 14, 2025 12:00 PM GMT
FREEHOLD, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced the issuance of a new standard patent by the Hong Kong Intel